GCCC 2578 Randomized Photon vs Proton RT for Newly Diagnosed Gynecologic Primaries
NCT07415681
This study is recruiting at 5 US sites in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
The purpose of study is to compare the side effects of two different forms of radiation for endometrial and cervical cancer. If you decide to enroll in this study, you will be randomized to one of two treatment groups. This study will compare two standard of care treatments: "Conventional" pHoton radiation versus pRoton radiation.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Gynaecologic Cancer
- Cervical Cancer
- Radiation Therapy
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 2
- Ages
- 18 years and older
- Sex
- Female
- Healthy volunteers
- Not accepted
- Sponsor
- University of Maryland, Baltimore
- Last updated on ClinicalTrials.gov
- August 10, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Maryland · 5
- Maryland Proton Treatment Center · Baltimore, MD
- University of Maryland Greenebaum Cancer Center · Baltimore, MD
- Upper Chesapeake Health · Bel Air, MD
- Central Maryland Radiation Oncology · Columbia, MD
- Baltimore Washington Medical Center- Tate Cancer Center · Glen Burnie, MD
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.